Best Hospitals for Cervical Conization (Cone Biopsy) in Chennai, India

The uterine cervix is a cylindrical structure connecting the uterine body to the vaginal vault, lined by a transformation zone where columnar and squamous epithelium meet — the site of origin for virtually all cervical dysplasias and carcinomas. Persistent infection with high-risk human papillomavirus (HPV) subtypes 16, 18, 31, and 33 drives a well-characterised progression from low-grade squamous intraepithelial lesion (LSIL/CIN I) through high-grade squamous intraepithelial lesion (HSIL/CIN II–III) and adenocarcinoma in situ (AIS), to frankly invasive squamous cell carcinoma or adenocarcinoma. Without treatment, CIN III carries a cumulative 30–50% risk of progression to invasion over 30 years, making timely excisional therapy both diagnostic and therapeutic.

• ELIGIBLE PATIENTS:
• Women with colposcopic biopsy-confirmed CIN II or CIN III (HSIL) in whom conservative surveillance is inappropriate (age ≥25, immunocompromise, poor compliance with follow-up, or persistent lesion >24 months)
• Women with adenocarcinoma in situ (AIS) of the cervix regardless of fertility intent (excision mandatory; hysterectomy preferred if childbearing complete)
• Women with a positive high-risk HPV co-test and unsatisfactory colposcopy (squamocolumnar junction not fully visualised) requiring diagnostic excision
• Women with discordant cytology–colposcopy (e.g., HSIL cytology with negative or CIN I biopsy) per ASCCP 2019 guidelines
• +16 more

LOOP ELECTROSURGICAL EXCISION PROCEDURE (LEEP / LLETZ): LEEP is the most widely performed first-line excisional technique globally and the preferred method at most Indian and UAE centres for CIN II/III confined to the ectocervix. A thin wire loop energised at 30–50 watts blended current excises the transformation zone in a single or two-pass technique under colposcopic guidance, typically under local anaesthesia (intracervical lignocaine 1–2% with adrenaline 1:100,000) as a day-case procedure. The large-loop excision of the transformation zone (LLETZ) technique removes a specimen averaging 10–15 mm in depth and 20–25 mm in diameter. Thermal artefact at the margins is the principal limitation; experienced operators limit this to <1 mm using optimised waveform settings. Haemostasis is achieved with a ball electrode at 40–60 watts coagulation current or Monsel's solution application. Reported clear-margin rates for CIN III: 85–92% on first excision.

COLD KNIFE CONIZATION (CKC): CKC is performed under general or regional anaesthesia in an operating theatre and remains the gold standard when glandular disease (AIS), microinvasive carcinoma, or a large endocervical lesion is suspected, because it produces thermally unaffected margins that allow unambiguous histopathological assessment. The surgeon uses a scalpel (size 11 or 15 blade) to excise a cone specimen tailored to colposcopic and ECC findings; Sturmdorf sutures or figure-of-eight haemostatic sutures control bleeding. Cone depth typically ranges from 20–25 mm for AIS cases. CKC has the lowest margin-positivity rate among excisional techniques for glandular lesions. It is also the preferred technique in pregnancy when excision is unavoidable. Estimated operative time: 20–40 minutes.

CO₂ LASER CONIZATION: Available at select high-volume gynecologic oncology centres in India (Tata Memorial Hospital, Apollo) and the UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai), CO₂ laser conization offers the advantage of simultaneous haemostasis and a precisely controlled ablation depth (operator-adjustable from 1–30 mm). The laser beam (focused spot size 0.2–0.5 mm, power density 500–2000 W/cm²) vaporises or excises tissue with minimal thermal spread (50–100 µm lateral damage zone), preserving margin clarity. It is particularly useful for women with prior LEEP who have cervical stenosis or a shortened ectocervix. The procedure is typically performed under local anaesthesia or brief sedation.

SEE-AND-TREAT STRATEGY: High-volume referral centres in India and the UAE routinely offer a combined colposcopy and LEEP in a single visit for patients with high-grade cytology and colposcopically visible high-grade lesions (acetowhite epithelium with mosaic/punctation, Reid Colposcopic Index ≥6), avoiding the delay and anxiety of a separate biopsy–wait–treatment pathway. This approach is consistent with ASCCP and BSCCP guidelines for appropriate patient selection and reduces overall healthcare contact burden for international medical tourists.

Pre-arrival (2–4 WEEKS Before TRAVEL):

• GAF Healthcare's medical coordination team reviews all prior cytology reports, colposcopy findings, biopsy histology, and HPV genotyping results via secure teleconsultation with the treating gynecologic oncologist.
• Pre-operative blood tests (CBC, coagulation, blood group, β-hCG, STI screen) can be completed at the patient's home country with results forwarded digitally; tests not available locally are repeated on Day 1 of arrival.
• Anaesthesia pre-assessment completed remotely for patients requiring general anaesthesia (ASA classification, airway assessment questionnaire, ECG if indicated by age/comorbidity).
• Any concurrent lower genital tract infection is treated and confirmed resolved before travel is booked.
• GAF Healthcare issues a detailed itinerary covering flight dates, airport transfer, hotel/hospital guest-house accommodation, and the procedure date.

DAY 1 — Arrival & Hospital REGISTRATION: